Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kairui Yue

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Journal of Medicinal Chemistry|November 11, 2025
Design, Synthesis, and Anti-inflammatory Activity Evaluation for Hydrazide-Based HDAC6 Targeted Protein DegradersSimin Sun, Kairui Yue, Enqiang Liu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 20, 2025
Targeting Histone Deacetylase 11 with a Highly Selective Inhibitor for the Treatment of MASLDFeng Zhang, Kairui Yue, Simin Sun, et al.
Bioorganic Chemistry|September 20, 2021
Design, synthesis and biological evaluation of hybrid of ubenimex-fluorouracil for hepatocellular carcinoma therapyKairui Yue, Xiaohan Hou, Geng Jia, et al.
Journal of Medicinal Chemistry|November 29, 2023
Discovery of Novel 2,3-Dihydro-1<i>H</i>-indene-5-sulfonamide NLRP3 Inflammasome Inhibitors Targeting Colon as a Potential Therapy for ColitisSimin Sun, Zhuoyue Li, Chao Huang, et al.
Journal of Medicinal Chemistry|December 23, 2021
Potent Hydrazide-Based HDAC Inhibitors with a Superior Pharmacokinetic Profile for Efficient Treatment of Acute Myeloid Leukemia In VivoYuqi Jiang, Jie Xu, Kairui Yue, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Journal of Medicinal Chemistry|November 11, 2025
Design, Synthesis, and Anti-inflammatory Activity Evaluation for Hydrazide-Based HDAC6 Targeted Protein DegradersSimin Sun, Kairui Yue, Enqiang Liu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 20, 2025
Targeting Histone Deacetylase 11 with a Highly Selective Inhibitor for the Treatment of MASLDFeng Zhang, Kairui Yue, Simin Sun, et al.
Bioorganic Chemistry|September 20, 2021
Design, synthesis and biological evaluation of hybrid of ubenimex-fluorouracil for hepatocellular carcinoma therapyKairui Yue, Xiaohan Hou, Geng Jia, et al.
Journal of Medicinal Chemistry|November 29, 2023
Discovery of Novel 2,3-Dihydro-1<i>H</i>-indene-5-sulfonamide NLRP3 Inflammasome Inhibitors Targeting Colon as a Potential Therapy for ColitisSimin Sun, Zhuoyue Li, Chao Huang, et al.
Journal of Medicinal Chemistry|December 23, 2021
Potent Hydrazide-Based HDAC Inhibitors with a Superior Pharmacokinetic Profile for Efficient Treatment of Acute Myeloid Leukemia In VivoYuqi Jiang, Jie Xu, Kairui Yue, et al.
Pageof 2